Osaka, Japan

Kosuke Tsukamoto

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Massachusetts Institute of Technology. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kosuke Tsukamoto. Retrieved from https://idiyas.com/inventor/kosuke-tsukamoto-4wy4npr9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kosuke Tsukamoto: Innovator in Tissue Damage Treatment

Introduction

Kosuke Tsukamoto is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of tissue damage associated with ischemia. His innovative approach utilizes apolipoprotein D (ApoD) to address critical health issues.

Latest Patents

Tsukamoto holds a patent for "Methods for treating tissue damage associated with ischemia with apolipoprotein D." This invention provides methods for treating tissue damage that occurs due to impaired blood flow. The use of ApoD, or an active variant thereof, plays a crucial role in this treatment. The invention also encompasses active variants of ApoD for use in these methods. He has 1 patent to his name.

Career Highlights

Kosuke Tsukamoto is affiliated with the Massachusetts Institute of Technology, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical treatments and patient care.

Collaborations

One of his notable collaborators is Monty Krieger, with whom he has worked on various projects related to his patent.

Conclusion

Kosuke Tsukamoto's contributions to the field of medical science through his innovative patent highlight the importance of research in treating tissue damage. His work exemplifies the potential of scientific advancements to improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…